Bertino JR - Search Results

1

Banerjee D, Schnieders B, Fu JZ, Adhikari D, Zhao SC, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Cancer Res. 1998 Oct 1;58(19):4292-6. Cancer Res. 1998. PMID: 9766655

2

p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.

Magro PG, Russo AJ, Li WW, Banerjee D, Bertino JR. Magro PG, et al. Among authors: bertino jr. Cancer Res. 2004 Jun 15;64(12):4338-45. doi: 10.1158/0008-5472.CAN-03-1045. Cancer Res. 2004. PMID: 15205349

3

Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.

Banerjee D, Zhao SC, Tong Y, Steinherz J, Gritsman K, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Cancer Gene Ther. 1994 Sep;1(3):181-4. Cancer Gene Ther. 1994. PMID: 7621249

4

Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.

Banerjee D, Lenz HJ, Schnieders B, Manno DJ, Ju JF, Spears CP, Hochhauser D, Danenberg K, Danenberg P, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Cell Growth Differ. 1995 Nov;6(11):1405-13. Cell Growth Differ. 1995. PMID: 8562479

5

Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.

Hochhauser D, Schnieders B, Ercikan-Abali E, Gorlick R, Muise-Helmericks R, Li WW, Fan J, Banerjee D, Bertino JR. Hochhauser D, et al. Among authors: bertino jr. J Natl Cancer Inst. 1996 Sep 18;88(18):1269-75. doi: 10.1093/jnci/88.18.1269. J Natl Cancer Inst. 1996. PMID: 8797766

6

Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase.

Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, Danenberg PV, Klimstra D, Jhanwar S, Cordon-Cardo C, Fong Y, Kemeny N, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Cancer Res. 2000 May 1;60(9):2365-7. Cancer Res. 2000. PMID: 10811110

7

Myeloprotection with drug-resistance genes.

Banerjee D, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Lancet Oncol. 2002 Mar;3(3):154-8. doi: 10.1016/s1470-2045(02)00678-2. Lancet Oncol. 2002. PMID: 11902501 Review.

8

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.

Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):164-73. doi: 10.1016/s0925-4439(02)00079-0. Biochim Biophys Acta. 2002. PMID: 12084458 Free article. Review.

9

Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo.

Takahashi N, Li W, Banerjee D, Guan Y, Wada-Takahashi Y, Brennan MF, Chou TC, Scotto KW, Bertino JR. Takahashi N, et al. Among authors: bertino jr. Cancer Res. 2002 Dec 1;62(23):6909-15. Cancer Res. 2002. PMID: 12460906

10

mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.

Sowers R, Toguchida J, Qin J, Meyers PA, Healey JH, Huvos A, Banerjee D, Bertino JR, Gorlick R. Sowers R, et al. Among authors: bertino jr. Mol Cancer Ther. 2003 Jun;2(6):535-41. Mol Cancer Ther. 2003. PMID: 12813132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters